Movilox-CF – Cefixime & Moxifloxacin Sustained-Release Tablets
Composition: Moxifloxacin 400mg SR + Cefixime 400mg
This combination is a broad-spectrum antibiotic therapy used for treating moderate to severe bacterial infections in adults. Doctors prescribe it for conditions such as: Respiratory tract infections (pneumonia, acute bronchitis, COPD exacerbations), ENT infections (tonsillitis, sinusitis, pharyngitis), Urinary tract infections (UTI), Skin and soft tissue infections and Complicated bacterial infections where dual coverage is required. Cefixime kills bacteria by breaking their cell wall, while Moxifloxacin stops their growth and prevents multiplication. The sustained-release form provides long-lasting action with convenient dosing. Use only under medical supervision and not for viral illnesses.
➣Active Ingredient: A strong combination of Moxifloxacin 400mg (sustained release) and Cefixime 400mg, designed to target a wide range of bacterial infections.
➣Dual Mechanism: Both antibiotics work together—Moxifloxacin stops bacterial growth by blocking DNA replication, while Cefixime disrupts cell wall formation. This dual approach helps control infections more effectively.
➣Better Tolerability: The sustained-release formulation ensures steady action with fewer stomach-related issues, making the treatment easier to tolerate for most adults.
➣Mode of Action: Moxifloxacin acts on bacterial enzymes essential for survival, and Cefixime weakens the bacterial cell wall. Together, they deliver strong, long-lasting antibacterial action for moderate to severe infections.
➣General Physicians
➣Pulmonologists
➣ENT Specialists
➣Infectious Disease Specialists
➣Dermatologists
➣Gastroenterologists / Urologists
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only
Copyright 2024-2025. All rights reserved. Design and Developed Website By Hivends Info Solutions Private Limited